State of the Art: Interventional Pulmonology

Momen M. Wahidi*, Felix J.F. Herth, Alexander Chen, George Cheng, Lonny Yarmus

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Interventional pulmonology (IP) has evolved over the past decade from an obscure subspecialty in pulmonary medicine to a recognized discipline offering advanced consultative and procedural services to patients with thoracic malignancy, anatomic airway disease, and pleural disease. Innovative interventions are now also available for diseases not traditionally treated procedurally, such as asthma and emphysema. The IP field has established certification examinations and training standards for IP training programs in an effort to enhance training quality and ensure competency. Validating new technology and proving its cost-effectiveness and effect on patient outcomes present the biggest challenge to IP as the health-care environment marches toward value-based health care. High-quality research is now thriving in IP and promises to elevate its practice into patient-centric evidence-based care.

Original languageEnglish (US)
Pages (from-to)724-736
Number of pages13
Issue number3
StatePublished - Mar 2020


  • bronchoscopy
  • interventional pulmonology
  • lung biopsy
  • lung neoplasm

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'State of the Art: Interventional Pulmonology'. Together they form a unique fingerprint.

Cite this